Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBATCF: Azithromycin for Prevention of Bronchiectasis in Infants with Cystic Fibrosis
NCT01270074Phase 3Completed
- Sponsor
- The University of Queensland
- Start
- Apr 2012
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azithromycin in cystic fibrosis (CF), sponsored by The University of Queensland. Started Apr 2012; status: completed.
02
Drugs
azithromycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01270074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270074.